TBPH Operating Cash Flow
Theravance Biopharma Inc · Operating Cash Flow
TBPH Operating Cash Flow
Latest reported$51.83Mperiod ending
TBPH Operating Cash Flow (-$83.43M → $51.83M)
Annual operating cash flow
High-resolution chart · PNG
TBPH operating cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 238,541,000 | |
| -11,535,000 | |
| -26,997,000 | |
| -186,991,000 | |
| -207,858,000 | |
| -250,403,000 | |
| -238,197,000 | |
| -112,867,000 | |
| -201,052,000 | |
| -98,989,000 | |
| -168,857,000 | |
| -175,155,000 | |
| -120,959,000 | |
| -119,107,000 | |
| -83,428,000 |